This guidance is intended to assist clinical investigators, sponsors, sponsor-investigators, and institutional review boards (IRBs) in determining whether research studies involving human subjects must be conducted under an investigational new drug application (IND).
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2tvNm4C
No comments:
Post a Comment